Reported results
- Revenues increased 3.6 percent to $19.849 billion.
- Net income attributable to HCA Healthcare, Inc. (GAAP) declined 3.9 percent to $1.579 billion.
- Diluted earnings per share (GAAP) increased 4.5 percent to $7.27 per diluted share.
- Diluted earnings per share, as adjusted (non-GAAP), increased 3.7 percent to $7.22 per diluted share.
- Adjusted EBITDA (non-GAAP) increased 1.2 percent to $3.918 billion.
- Same facility admissions increased 2.7 percent and same facility equivalent admissions increased 3.0 percent.
Guidance
- The Company now believes its full year operating results will be in the upper half of its 2026 estimated guidance ranges previously issued on July 14, 2026.
- Forecasted revenues for the year ending December 31, 2026 are $77,000 million to $79,500 million.
- Forecasted net income attributable to HCA Healthcare, Inc. (GAAP) for the year ending December 31, 2026 is $6,300 million to $6,700 million.
- Forecasted Adjusted EBITDA (non-GAAP) for the year ending December 31, 2026 is $15,400 million to $16,100 million.
- Forecasted diluted earnings per share (GAAP) for the year ending December 31, 2026 is $28.70 to $30.50.
Price and volatility reaction
The stock moved -3.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -8.2 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 465.26 | 2026-10-26 |
| Close after release | 449.96 | 2026-10-27 |
| Realised move | -3.3% | close to close |
| 30d ATM IV change | -8.2 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.
